Friedreich's Ataxia

Biogen to acquire rare disease drugmaker Reata for $7.3B
Biogen to acquire rare disease drugmaker Reata for $7.3B
BioPharma Dive
Biogen
Reata Pharmaceuticals
M&A
Friedreich's Ataxia
Flag link:
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
PTC Therapeutics
Friedreich's Ataxia
clinical trials
vatiquinone
Flag link:
FDA Approves First Therapy for Friedreich's Ataxia
FDA Approves First Therapy for Friedreich's Ataxia
BioSpace
Reata Pharmaceuticals
FDA
Friedreich's Ataxia
Flag link:
FDA scraps AdComm for Reata's rare disease candidate, leaving analysts squinting at the tea leaves
FDA scraps AdComm for Reata's rare disease candidate, leaving analysts squinting at the tea leaves
Fierce Biotech
Reata Pharmaceuticals
omaveloxolone
FDA
Friedreich's Ataxia
Flag link:
Larimar to respond to FDA this quarter on 15-month clinical hold of PhI Friedreich's ataxia drug
Larimar to respond to FDA this quarter on 15-month clinical hold of PhI Friedreich's ataxia drug
Endpoints
Larimar Therapeutics
CTI-1601
clinical trials
FDA
Friedreich's Ataxia
Flag link:
Reata’s ‘regulatory concerns’ turn into three-month delay on FDA decision for Friedreich’s ataxia drug
Reata’s ‘regulatory concerns’ turn into three-month delay on FDA decision for Friedreich’s ataxia drug
Endpoints
Reata Pharmaceuticals
Friedreich's Ataxia
FDA
omaveloxolone
Flag link:
Larimar kept in limbo as FDA maintains clinical hold on leading candidate
Larimar kept in limbo as FDA maintains clinical hold on leading candidate
Fierce Biotech
Larimar Therapeutics
Friedreich's Ataxia
FDA
clinical hold
CTI-1601
Flag link:
FDA places clinical hold on Larimar’s rare disease drug after deaths in monkey study
FDA places clinical hold on Larimar’s rare disease drug after deaths in monkey study
MedCity News
Larimar
clinical trials
Friedreich's Ataxia
FDA
clinical hold
Flag link:
Healx deploys its AI in hunt for Friedreich’s ataxia therapies
Healx deploys its AI in hunt for Friedreich’s ataxia therapies
Pharmaforum
Healx
artificial intelligence
Friedreich's Ataxia
Flag link:
Reata Pharmaceuticals Sees Hiccup in Filing for Approval of FA Drug
Reata Pharmaceuticals Sees Hiccup in Filing for Approval of FA Drug
BioSpace
Reata Pharmaceuticals
Friedreich's Ataxia
omaveloxolone
Flag link:
Reata shocks analysts with pivotal win in Friedreich's ataxia
Reata shocks analysts with pivotal win in Friedreich's ataxia
Fierce Biotech
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
clinical trials
Flag link:
Reata gets another shot in Friedreich’s ataxia
Reata gets another shot in Friedreich’s ataxia
EP Vantage
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
Flag link:
RegenxBio and Pfizer Partner on Gene Therapy for Friedreich's Ataxia
RegenxBio and Pfizer Partner on Gene Therapy for Friedreich's Ataxia
BioSpace
Regenxbio
Pfizer
gene therapy
Friedreich's Ataxia
Flag link:
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
Yahoo/AP
ViroPharma
Intellect Neurosciences
Friedreich's Ataxia
OX1
Flag link: